- Covishield, Covaxin approved
- The vaccines are 110 percent safe: Drug Controller General of India
- Both vaccines to be administered in two doses
- Can be stored in normal refrigerator
New Delhi: It is indeed a red-letter day for India today as two vaccines for COVID-19 produced by Pune-based Serum Institute’s Covishield and Bharat Biotech’s Covaxin, received emergency approval from the country’s drug regulator this morning.






